The Enterprise Value as of June 2026 (TTM) for Aeglea BioTherapeutics, Inc. (AGLE) is 4.94B

According to Aeglea BioTherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.94B. This represents a change of -35.47% compared to the average of 7.66B of the last 4 quarters.

Aeglea BioTherapeutics, Inc. (AGLE) Historical Enterprise Value (quarterly & annually)

How has AGLE Enterprise Value performed in the past?

The mean historical Enterprise Value of Aeglea BioTherapeutics, Inc. over the last ten years is 1.33B. The current 4.94B Enterprise Value has changed 37.08% with respect to the historical average. Over the past ten years (40 quarters), AGLE's Enterprise Value was at its highest in in the March 2026 quarter at 17.36B. The Enterprise Value was at its lowest in in the June 2023 quarter at -187908015.60.

Aeglea BioTherapeutics, Inc. (AGLE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aeglea BioTherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aeglea BioTherapeutics, Inc. (AGLE) Average Enterprise Value

How has AGLE Enterprise Value performed in the past?

The current Enterprise Value of Aeglea BioTherapeutics, Inc. (AGLE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aeglea BioTherapeutics, Inc. (AGLE) Enterprise Value vs. Peers

How is AGLE’s Enterprise Value compared to its peers?

Aeglea BioTherapeutics, Inc.’s Enterprise Value is greater than bluebird bio, Inc. (158.07M), greater than GreenLight Biosciences Holdings (57.81M), greater than Lunai Bioworks Inc. (11.16M), greater than AlloVir, Inc. (48.71M), greater than Rein Therapeutics Inc. (26.90M), greater than ERYTECH Pharma S.A. (3.80M), greater than Kronos Bio, Inc. (-13835104.00), greater than Magenta Therapeutics, Inc. (-583861976.00), greater than TCR2 Therapeutics Inc. (79.12M), greater than Pluristem Therapeutics Inc. (43.64M),

Build a custom stock screener for Aeglea BioTherapeutics, Inc. (AGLE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aeglea BioTherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aeglea BioTherapeutics, Inc. (AGLE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aeglea BioTherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.